Does the science lose relevance?, page-34

If anticipating a CR is the overriding reason short sellers are taking their positions then they are going to be very disappointed with the eventual outcome. A CR is not going to happen. More likely a cornerstone investor will come in if and when further capital is required. I doubt the board will do a CR and give short sellers the satisfaction of making profit by circulating false rumours of an imminent CR into the market. Head to head trial results with 68Ga-PSMA-11 can’t be too far away and I see this as a turning point. Proof that 64CuSAR-bis-PMSA detects more lesions and sooner than its future competitors is a game changer. Lives will be saved because of this and FDA will get it onto market ASAP, probably sometime towards the end of 2026. That market will be worth more than $3B in a few years from now and potentially Clarity will take it all. I haven’t even started talking about the therapy side with Cu67 either. I will say, based on what I’ve seen from the Secure trial results so far, things are looking good for current and future shareholders once we get through these challenging times. Just a matter of hanging in there if you can. Good luck to all during this tumultuous period!